Panacea Medical Technologies Pvt. Ltd. has garnered official validation of its steadfast commitment to diminish greenhouse gas emissions. Through a comprehensive assessment conducted by the Science Based Targets initiative (SBTi) — a collaborative endeavor led by CDP, the United Nations Global Compact, World Resources Institute (WRI), and the World Wide Fund for Nature (WWF) — Panacea’s emission reduction targets have been endorsed and recognized as credible.

Under the visionary leadership of G.V. Subramanyam, Managing Director of Panacea, the company has embarked on a comprehensive approach to minimize its environmental impact. With a target of reducing emissions by 42% by 2030 from the base year 2022, Panacea aligns its goals with the ambitious 1.5-degree trajectory outlined in the Paris Climate Accord, aiming to mitigate the adverse effects of global warming.

This recognition by SBTi marks a significant milestone for Panacea, making it the first and only Indian manufacturer in the healthcare equipment and supplies sector to commit to such ambitious emission reduction targets.

Panacea’s commitment to sustainability extends beyond mere compliance; it reflects a deep-rooted ethos of environmental stewardship and corporate responsibility. By prioritizing emission reduction initiatives, Panacea not only safeguards the planet for future generations but also demonstrates leadership within the industry, inspiring others to follow suit.